+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wearable Injectors Market By Type, Usage, Technology, Mechanism Of Injection, Therapeutic Area and End User: Global Opportunity Analysis And Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 344 Pages
  • December 2021
  • Region: Global
  • Allied Market Research
  • ID: 5548412
The global wearable injectors market was valued at $5,022.2 million in 2020, and is projected to reach $19,518.9 million by 2030, registering a CAGR of 15.3% from 2021 to 2030.



Wearable injectors are devices that are comfortably worn on the body and the drug such as insulin is subcutaneously administered over a pre-programmed period spanning seconds or hours. Upon full injection of the dose, they are removed from the body and conveniently disposed. Wearable injectors are economical, when compared to intravenous (IV) infusion drug administration at home, therefore, they have the potential to save a substantial amount of money in total healthcare expenditures. Wearable injectors allow self-administration of a therapy without medical supervision and reduce burden on healthcare practitioners. In addition, they are suitable for highly viscous fluids such as therapeutic proteins like monoclonal antibodies, cytokinin, insulin, and antigens. The biologic drugs are highly viscous in nature which poses substantial challenges in drug delivery owing to their large size and susceptibility to degradation, hence large volume wearable injectors used to deliver such biologic drugs to the patients. For instance, Eitan Medical, a leading manufacturer of wearable injectors, offers Sorrel, a wearable injector platform with different capacities of drug delivery ranging up to 25 ml.

Development of advanced wearable injectors and advantages over traditional IV infusion drives growth of the wearable injector market. In addition, increase in adoption of home-based treatments, owing to the impact of COVID-19 propel growth of the wearable injector market. Wearable injectors can release drug throughout the set period with specific time intervals, thus it can be used for long term therapy.

Rise in prevalence of chronic diseases such as cancer, diabetes, kidney diseases, respiratory diseases, and arthritis contributes toward growth of the market. For instance, according to the World Health Organization (WHO) in 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes in the world. Cancer has become one of the leading cause of death worldwide. As per the American Cancer Society Journal, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020, globally. Rise in geriatric population also contributes toward growth of the market. Wearable injectors are useful for geriatric patients receiving daily medication, giving them convenient experience. For instance, as per data by the Population Reference Bureau (PRB), in 2019, about 52.76 million people were over the age of 65 in the U.S.

However, some drugs are highly potent and may produce toxic effects such as anti-cancer requires physician monitoring, which limits usability of wearable injectors. In addition, high cost associated with manufacturing of devices in developing and underdeveloped countries also limit growth of the market. Moreover, a single type of wearable injector is not suitable for all drugs, hence manufacturers, while designing a device, focus on specific category of medication, which limits its usage.

The wearable injector market is segmented on the basis of type, usage, technology, mechanism of injection, therapeutic area, end user, and region. By type, the market is divided into on body (adhesive patch), off body (belt held), and hand held. By usage, it is classified into disposable and semi-reusable. By technology, it is classified into electronic injectors, mechanical injectors, and others. By mechanism of injection, it is categorized as motor driven, spring driven, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. By therapeutic area, it is divided into diabetes, oncology, cardiovascular disease, infectious disease, and auto immune disorder. By end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global wearable injector market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable injector market growth

KEY MARKET SEGMENTS


By Type

  • On body
  • Off body

By Usage

  • Disposable
  • Semi-reusable

By Technology

  • Electronic injectors
  • Mechanical injectors
  • Others

By Mechanism of Injection

  • Motor driven
  • Spring driven
  • Expanding battery
  • Rotary pump
  • Collapsible reservoir
  • Pressurized gas

By Therapeutic Area

  • Diabetes
  • Oncology
  • Cardiovascular disease
  • Other

By End User

  • Clinics
  • Hospital
  • Ambulatory surgery centers
  • Home care setting
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Enable injections
  • United therapeutics (Steadymed therapeutics, inc.)
  • Insulet corporation
  • Medtronic plc
  • Sensile medical ag
  • West pharmaceutical services, inc.
  • Becton, dickinson and company
  • Buhler motor gmbh
  • Ypsomed
  • Eoflow

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

  • Amgen
  • Sorrel medical
  • Philips
Frequently Asked Questions about the Global Wearable Injectors Market

What is the estimated value of the Global Wearable Injectors Market?

The Global Wearable Injectors Market was estimated to be valued at $5022.2 million in 2020.

What is the growth rate of the Global Wearable Injectors Market?

The growth rate of the Global Wearable Injectors Market is 14.5%, with an estimated value of $19518.9 million by 2030.

What is the forecasted size of the Global Wearable Injectors Market?

The Global Wearable Injectors Market is estimated to be worth $19518.9 million by 2030.

Who are the key companies in the Global Wearable Injectors Market?

Key companies in the Global Wearable Injectors Market include Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic Plc, Sensile Medical Ag, West Pharmaceutical Services Inc., Becton Dickinson And Company, Buhler Motor Gmbhy and Eoflow.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Shift of healthcare system toward home-based treatment due to COVID-19
3.5.1.2. Rise in demand for quality and affordable patient care
3.5.1.3. Advancements in wearable injectors
3.5.2. Restraint
3.5.2.1. Low volume of administration and nature of drugs
3.5.3. Opportunity
3.5.3.1. Increase in prevalence of chronic disorders.
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the wearable injector market
3.7. Patent Analysis (2018–2021)
3.7.1. Patent analysis, by year
3.7.2. Patent analysis for year 2020, by country
3.8. Clinical Trial Analysis (2018–2021)
CHAPTER 4: WEARABLE INJECTOR MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. On body
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Off-body
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: WEARABLE INJECTOR MARKET, BY USAGE
5.1. Overview
5.1.1. Market size and forecast
5.2. Disposable
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Semi-reusable
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: WEARABLE INJECTOR MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Electronic injector
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Mechanical injectors
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Other
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: WEARABLE INJECTOR MARKET, BY MECHANISM OF INJECTION
7.1. Overview
7.1.1. Market size and forecast
7.2. Motor driven
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market analysis, by country
7.3. Spring-based
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market analysis, by country
7.4. Expanding battery
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market analysis, by country
7.5. Rotary pump
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market analysis, by country
7.6. Collapsible reservoir
7.6.1. Key market trends, growth factors, and opportunities
7.6.2. Market size and forecast, by region
7.6.3. Market analysis, by country
7.7. Pressurized gas
7.7.1. Key market trends, growth factors, and opportunities
7.7.2. Market size and forecast, by region
7.7.3. Market analysis, by country
CHAPTER 8: WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA
8.1. Overview
8.1.1. Market size and forecast
8.2. Diabetes
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market analysis, by country
8.3. Oncology
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market analysis, by country
8.4. Cardiovascular diseases
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by region
8.4.3. Market analysis, by country
8.5. Others
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by region
8.5.3. Market analysis, by country
CHAPTER 9: WEARABLE INJECTOR MARKET, BY END USER
9.1. Overview
9.1.1. Market size and forecast
9.2. Clinics
9.2.1. Key market trends, growth factors, and opportunities
9.2.2. Market size and forecast, by region
9.2.3. Market analysis, by country
9.3. Hospitals
9.3.1. Key market trends, growth factors, and opportunities
9.3.2. Market size and forecast, by region
9.3.3. Market analysis, by country
9.4. Ambulatory surgery centers
9.4.1. Key market trends, growth factors, and opportunities
9.4.2. Market size and forecast, by region
9.4.3. Market analysis, by country
9.5. Home care settings
9.5.1. Key market trends, growth factors, and opportunities
9.5.2. Market size and forecast, by region
9.5.3. Market analysis, by country
9.6. Others
9.6.1. Key market trends, growth factors, and opportunities
9.6.2. Market size and forecast, by region
9.6.3. Market analysis, by country
CHAPTER 10: WEARABLE INJECTOR MARKET, BY REGION
10.1. Overview
10.1.1. Market size and forecast
10.2. North America
10.2.1. Key market trends, growth factors, and opportunities
10.2.2. North America wearable injector market, by type
10.2.3. North America wearable injector market, by usage
10.2.4. North America wearable injector market, by technology
10.2.5. North America wearable injector market, by mechanism of action
10.2.6. North America wearable injector market, by therapeutic area
10.2.7. North America wearable injector market, by end user
10.2.8. Market size and forecast, by country
10.2.8.1. U.S.
10.2.8.1.1. U.S. wearable injector market, by type
10.2.8.1.2. U.S. wearable injector market, by usage
10.2.8.1.3. U.S. wearable injector market, by technology
10.2.8.1.4. U.S. wearable injector market, by mechanism of action
10.2.8.1.5. U.S. wearable injector market, by therapeutic area
10.2.8.1.6. U.S. wearable injector market, by end user
10.2.8.2. Canada
10.2.8.2.1. Canada wearable injector market, by type
10.2.8.2.2. Canada. wearable injector market, by usage
10.2.8.2.3. Canada wearable injector market, by technology
10.2.8.2.4. Canada wearable injector market, by mechanism of action
10.2.8.2.5. Canada wearable injector market, by therapeutic area
10.2.8.2.6. Canada wearable injector market, by end user
10.2.8.3. Mexico
10.2.8.3.1. Mexico wearable injector market, by type
10.2.8.3.2. Mexico wearable injector market, by usage
10.2.8.3.3. Mexico wearable injector market, by technology
10.2.8.3.4. Mexico wearable injector market, by mechanism of action
10.2.8.3.5. Mexico wearable injector market, by therapeutic area
10.2.8.3.6. Mexico wearable injector market, by end user
10.3. Europe
10.3.1. Key market trends, growth factors, and opportunities
10.3.2. Europe wearable injector market, by type
10.3.3. Europe wearable injector market, by usage
10.3.4. Europe wearable injector market, by technology
10.3.5. Europe wearable injector market, by mechanism of action
10.3.6. Europe wearable injector market, by therapeutic area
10.3.7. Europe wearable injector market, by end user
10.3.8. Market size and forecast, by country
10.3.8.1. Germany
10.3.8.1.1. Germany wearable injector market, by type
10.3.8.1.2. Germany wearable injector market, by usage
10.3.8.1.3. Germany wearable injector market, by technology
10.3.8.1.4. Germany wearable injector market, by mechanism of action
10.3.8.1.5. Germany wearable injector market, by therapeutic area
10.3.8.1.6. Germany wearable injector market, by end user
10.3.8.2. France
10.3.8.2.1. France wearable injector market, by type
10.3.8.2.2. France wearable injector market, by usage
10.3.8.2.3. France wearable injector market, by technology
10.3.8.2.4. France wearable injector market, by mechanism of action
10.3.8.2.5. France wearable injector market, by therapeutic area
10.3.8.2.6. France wearable injector market, by end user
10.3.8.3. UK
10.3.8.3.1. UK wearable injector market, by type
10.3.8.3.2. UK wearable injector market, by usage
10.3.8.3.3. UK wearable injector market, by technology
10.3.8.3.4. UK wearable injector market, by mechanism of action
10.3.8.3.5. UK wearable injector market, by therapeutic area
10.3.8.3.6. UK wearable injector market, by end user
10.3.8.4. Italy
10.3.8.4.1. Italy wearable injector market, by type
10.3.8.4.2. Italy wearable injector market, by usage
10.3.8.4.3. Italy wearable injector market, by technology
10.3.8.4.4. Italy wearable injector market, by mechanism of action
10.3.8.4.5. Italy wearable injector market, by therapeutic area
10.3.8.4.6. Italy wearable injector market, by end user
10.3.8.5. Spain
10.3.8.5.1. Spain wearable injector market, by type
10.3.8.5.2. Spain wearable injector market, by usage
10.3.8.5.3. Spain wearable injector market, by technology
10.3.8.5.4. Spain wearable injector market, by mechanism of action
10.3.8.5.5. Spain wearable injector market, by therapeutic area
10.3.8.5.6. Spain wearable injector market, by end user
10.3.8.6. Rest of Europe
10.3.8.6.1. Rest of Europe wearable injector market, by type
10.3.8.6.2. Rest of Europe wearable injector market, by usage
10.3.8.6.3. Rest of Europe wearable injector market, by technology
10.3.8.6.4. Rest of Europe wearable injector market, by mechanism of action
10.3.8.6.5. Rest of Europe wearable injector market, by therapeutic area
10.3.8.6.6. Rest of Europe wearable injector market, by end user
10.4. Asia-Pacific
10.4.1. Key market trends, growth factors, and opportunities
10.4.2. Asia-pacific wearable injector market, by type
10.4.3. Asia-pacific wearable injector market, by usage
10.4.4. Asia-pacific wearable injector market, by technology
10.4.5. Asia-pacific wearable injector market, by mechanism of action
10.4.6. Asia-pacific wearable injector market, by therapeutic area
10.4.7. Asia-pacific wearable injector market, by end user
10.4.8. Market size and forecast, by country
10.4.8.1. Japan
10.4.8.1.1. Japan wearable injector market, by type
10.4.8.1.2. Japan wearable injector market, by usage
10.4.8.1.3. Japan wearable injector market, by technology
10.4.8.1.4. Japan wearable injector market, by mechanism of action
10.4.8.1.5. Japan wearable injector market, by therapeutic area
10.4.8.1.6. Japan wearable injector market, by end user
10.4.8.2. China
10.4.8.2.1. China wearable injector market, by type
10.4.8.2.2. China wearable injector market, by usage
10.4.8.2.3. China wearable injector market, by technology
10.4.8.2.4. China wearable injector market, by mechanism of action
10.4.8.2.5. China wearable injector market, by therapeutic area
10.4.8.2.6. China wearable injector market, by end user
10.4.8.3. Australia
10.4.8.3.1. Australia wearable injector market, by type
10.4.8.3.2. Australia wearable injector market, by usage
10.4.8.3.3. Australia wearable injector market, by technology
10.4.8.3.4. Australia wearable injector market, by mechanism of action
10.4.8.3.5. Australia wearable injector market, by therapeutic area
10.4.8.3.6. Australia wearable injector market, by end user
10.4.8.4. India
10.4.8.4.1. India wearable injector market, by type
10.4.8.4.2. India wearable injector market, by usage
10.4.8.4.3. India wearable injector market, by technology
10.4.8.4.4. India wearable injector market, by mechanism of action
10.4.8.4.5. India wearable injector market, by therapeutic area
10.4.8.4.6. India wearable injector market, by end user
10.4.8.5. South Korea
10.4.8.5.1. South Korea wearable injector market, by type
10.4.8.5.2. South Korea wearable injector market, by usage
10.4.8.5.3. South Korea wearable injector market, by technology
10.4.8.5.4. South Korea wearable injector market, by mechanism of action
10.4.8.5.5. South Korea wearable injector market, by therapeutic area
10.4.8.5.6. South Korea wearable injector market, by end user
10.4.8.6. Rest of Asia-Pacific
10.4.8.6.1. Rest of Asia-Pacific wearable injector market, by type
10.4.8.6.2. Rest of Asia-Pacific wearable injector market, by usage
10.4.8.6.3. Rest of Asia-Pacific Rest of Asia-Pacific wearable injector market, by technology
10.4.8.6.4. Rest of Asia-Pacific Rest of Asia-Pacific wearable injector market, by mechanism of action
10.4.8.6.5. Rest of Asia-Pacific Rest of Asia-Pacific wearable injector market, by therapeutic area
10.4.8.6.6. Rest of Asia-Pacific wearable injector market, by end user
10.5. LAMEA
10.5.1. Key market trends, growth factors, and opportunities
10.5.2. LAMEA wearable injector market, by type
10.5.3. LAMEA wearable injector market, by usage
10.5.4. LAMEA wearable injector market, by technology
10.5.5. LAMEA wearable injector market, by mechanism of action
10.5.6. LAMEA wearable injector market, by therapeutic area
10.5.7. LAMEA wearable injector market, by end user
10.5.8. Market size and forecast, by country
10.5.8.1. Brazil
10.5.8.1.1. Brazil wearable injector market, by type
10.5.8.1.2. Brazil wearable injector market, by usage
10.5.8.1.3. Brazil wearable injector market, by technology
10.5.8.1.4. Brazil wearable injector market, by mechanism of action
10.5.8.1.5. Brazil wearable injector market, by therapeutic area
10.5.8.1.6. Brazil wearable injector market, by end user
10.5.8.2. Saudi Arabia
10.5.8.2.1. Saudi Arabia wearable injector market, by type
10.5.8.2.2. Saudi Arabia wearable injector market, by usage
10.5.8.2.3. Saudi Arabia wearable injector market, by technology
10.5.8.2.4. Saudi Arabia wearable injector market, by mechanism of action
10.5.8.2.5. Saudi Arabia wearable injector market, by therapeutic area
10.5.8.2.6. Saudi Arabia wearable injector market, by end user
10.5.8.3. South Africa
10.5.8.3.1. South Africa wearable injector market, by type
10.5.8.3.2. South Africa wearable injector market, by usage
10.5.8.3.3. South Africa wearable injector market, by technology
10.5.8.3.4. South Africa wearable injector market, by mechanism of action
10.5.8.3.5. South Africa wearable injector market, by therapeutic area
10.5.8.3.6. South Africa wearable injector market, by end user
10.5.8.4. Rest of LAMEA
10.5.8.4.1. Rest of LAMEA wearable injector market, by type
10.5.8.4.2. Rest of LAMEA wearable injector market, by usage
10.5.8.4.3. Rest of LAMEA wearable injector market, by technology
10.5.8.4.4. Rest of LAMEA wearable injector market, by mechanism of action
10.5.8.4.5. Rest of LAMEA wearable injector market, by therapeutic area
10.5.8.4.6. Rest of LAMEA wearable injector market, by end user
CHAPTER 11: COMPANY PROFILES
11.1. BECTON DICKINSON AND COMPANY
11.1.1. Company overview
11.1.2. Company snapshot
11.1.3. Operating business segments
11.1.4. Product portfolio
11.1.5. Business performance
11.2. BUHLER MOTOR GmbH
11.2.1. Company overview
11.2.2. Company snapshot
11.2.3. Operating business segments
11.2.4. Product portfolio
11.2.5. Business performance
11.3. ENABLE INJECTION
11.3.1. Company overview
11.3.2. Company snapshot
11.3.3. Operating business segments
11.3.4. Product portfolio
11.3.5. Key strategic moves and developments
11.4. EOFLOW CO. LTD.
11.4.1. Company overview
11.4.2. Company snapshot
11.4.3. Operating business segments
11.4.4. Product portfolio
11.5. GERRESHEIMER ADVANCED TECHNOLOGIES
11.5.1. Company overview
11.5.2. Company snapshot
11.5.3. Operating business segments
11.5.4. Product portfolio
11.5.5. Business performance
11.5.6. Key strategic moves and developments
11.6. INSULET CORPORATION
11.6.1. Company overview
11.6.2. Company snapshot
11.6.3. Operating business segments
11.6.4. Product portfolio
11.6.5. Business performance
11.6.6. Key strategic moves and developments
11.7. MEDTRONIC PLC.
11.7.1. Company overview
11.7.2. Company snapshot
11.7.3. Operating business segment
11.7.4. Product portfolio
11.7.5. Business performance
11.8. UNITED THERAPEUTICS CORPORATION.
11.8.1. Company overview
11.8.2. Company snapshot
11.8.3. Operating business segments
11.8.4. Product portfolio
11.8.5. Business performance
11.8.6. Key strategic moves and developments
11.9. WEST PHARMACEUTICAL SERVICES, INC
11.9.1. Company overview
11.9.2. Company snapshot
11.9.3. Operating business segments
11.9.4. Product portfolio
11.9.5. Business performance
11.10. YPSOMED AG
11.10.1. Company overview
11.10.2. Company snapshot
11.10.3. Operating business segments
11.10.4. Product portfolio
11.10.5. Business performance
11.10.6. Key strategic moves and developments
List of Tables
TABLE 01. WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. WEARABLE INJECTOR MARKET FOR ON-BODY INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 03. WEARABLE INJECTOR MARKET FOR OFF-BODY , BY REGION, 2020-2030 ($MILLION)
TABLE 04. WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 05. WEARABLE INJECTOR MARKET FOR DISPOSABLE INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. WEARABLE INJECTOR MARKET FOR SEMI-REUSABLE INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 07. WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 08. WEARABLE INJECTOR MARKET FOR ELECTRONIC INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 09. WEARABLE INJECTOR MARKET FOR MECHANICAL INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. WEARABLE INJECTOR MARKET FOR OTHER INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 12. WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. WEARABLE INJECTOR MARKET FOR SPRING-BASED INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 14. WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 15. WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 16. WEARABLE INJECTOR MARKET FOR COLLAPSIBLE RESERVOIR, BY REGION, 2020-2030 ($MILLION)
TABLE 17. WEARABLE INJECTOR MARKET FOR PRESSURIZED GAS INJECTORS, BY REGION, 2020-2030 ($MILLION)
TABLE 18. WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 19. WEARABLE INJECTOR MARKET FOR DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 20. WEARABLE INJECTOR MARKET FOR ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 21. WEARABLE INJECTOR MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2020-2030 ($MILLION)
TABLE 22. WEARABLE INJECTOR MARKET FOR OTHER, BY REGION, 2020-2030 ($MILLION)
TABLE 23. WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 24. WEARABLE INJECTOR MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 25. WEARABLE INJECTOR MARKET FOR HOSPITALS, 2020-2030 ($MILLION)
TABLE 26. WEARABLE INJECTOR MARKET FOR AMBULATORY SURGERY CENTERS 2020-2030 ($MILLION)
TABLE 27. WEARABLE INJECTOR MARKET FOR HOME CARE SETTINGS 2020-2030 ($MILLION)
TABLE 28. WEARABLE INJECTOR MARKET FOR OTHER, 2020-2030 ($MILLION)
TABLE 29. WEARABLE INJECTOR MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 30. NORTH AMERICA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 31. NORTH AMERICA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 32. NORTH AMERICA WEARABLE INJECTOR, BY TEHNOLOGY, 2020-2030 ($MILLION)
TABLE 33. NORTH AMERICA WEARABLE INJECTOR, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 34. NORTH AMERICA WEARABLE INJECTOR, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 35. NORTH AMERICA WEARABLE INJECTOR, BY END USER, 2020-2030 ($MILLION)
TABLE 36. NORTH AMERICA WEARABLE INJECTOR MARKET WAS VALUED, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 37. U.S. WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 38. U.S. WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 39. U.S. WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 40. U.S. WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 41. U.S. WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 42. U.S. WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 43. CANADA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 44. CANADA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 45. CANADA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 46. CANADA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 47. CANADA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 48. CANADA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49. MEXICO WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 50. MEXICO WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 51. MEXICO WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 52. MEXICO WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 53. MEXICO WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 54. MEXICO WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55. EUROPE WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56. EUROPE WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 57. EUROPE WEARABLE INJECTOR, BY TEHNOLOGY, 2020-2030 ($MILLION)
TABLE 58. EUROPE WEARABLE INJECTOR, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 59. EUROPE WEARABLE INJECTOR, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 60. EUROPE WEARABLE INJECTOR, BY END USER, 2020-2030 ($MILLION)
TABLE 61. EUROPE WEARABLE INJECTOR MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 62. GERMANY WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 63. GERMANY WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 64. GERMANY WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 65. GERMANY WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 66. GERMANY WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 67. GERMANY WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 68. FRANCE WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 69. FRANCE WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 70. FRANCE WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 71. FRANCE WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 72. FRANCE WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 73. FRANCE WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 74. UK WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 75. UK WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 76. UK WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 77. UK WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 78. UK WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 79. UK WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80. ITALY WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81. ITALY WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 82. ITALYWEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 83. ITALY WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 84. ITALYWEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 85. ITALY WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86. SPAIN WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 87. SPAIN WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 88. SPAIN WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 89. SPAIN WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 90. SPAIN WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 91. SPAIN WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 92. REST OF EUROPE WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 93. REST OF EUROPE WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 94. REST OF EUROPE WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 95. REST OF EUROPE WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 96. REST OF EUROPE WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 97. REST OF EUROPE WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 98. ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 99. ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 100. ASIA-PACIFIC WEARABLE INJECTOR, BY TEHNOLOGY, 2020-2030 ($MILLION)
TABLE 101. ASIA-PACIFIC WEARABLE INJECTOR, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 102. ASIA-PACIFIC WEARABLE INJECTOR, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 103. ASIA-PACIFIC WEARABLE INJECTOR, BY END USER, 2020-2030 ($MILLION)
TABLE 104. ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 105. JAPAN WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 106. JAPAN WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 107. JAPAN WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 108. JAPAN WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 109. JAPAN WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 110. JAPAN WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 111. CHINA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 112. CHINA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 113. CHINA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 114. CHINA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 115. CHINA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 116. CHINA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 117. AUSTRALIA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 118. AUSTRALIA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 119. AUSTRALIA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 120. AUSTRALIA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 121. AUSTRALIA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 122. AUSTRALIA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 123. INDIA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 124. INDIA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 125. INDIA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 126. INDIA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 127. INDIA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 128. INDIA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 129. SOUTH KOREA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 130. SOUTH KOREA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 131. SOUTH KOREA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 132. SOUTH KOREA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 133. SOUTH KOREA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 134. SOUTH KOREA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 135. REST OF ASIA-PACIFIC REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 136. REST OF ASIA-PACIFIC REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 137. REST OF ASIA-PACIFIC REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 138. REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 139. REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 140. REST OF ASIA-PACIFIC WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 141. LAMEA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 142. LAMEA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 143. LAMEA WEARABLE INJECTOR, BY TEHNOLOGY, 2020-2030 ($MILLION)
TABLE 144. LAMEA WEARABLE INJECTOR, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 145. LAMEA WEARABLE INJECTOR, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 146. LAMEA WEARABLE INJECTOR, BY END USER, 2020-2030 ($MILLION)
TABLE 147. LAMEA WEARABLE INJECTOR MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 148. BRAZIL WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 149. BRAZIL WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 150. BRAZIL WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 151. BRAZIL WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 152. BRAZIL WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 153. BRAZIL WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 154. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 155. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 156. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 157. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 158. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 159. SAUDI ARABIA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 160. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 161. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 162. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 163. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 164. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 165. SOUTH AFRICA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 166. REST OF LAMEA WEARABLE INJECTOR MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 167. REST OF LAMEA WEARABLE INJECTOR MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 168. REST OF LAMEA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 169. REST OF LAMEA WEARABLE INJECTOR MARKET, BY MECHANISM OF ACTION, 2020-2030 ($MILLION)
TABLE 170. REST OF LAMEA WEARABLE INJECTOR MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 171. REST OF LAMEA WEARABLE INJECTOR MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 172. BD: COMPANY SNAPSHOT
TABLE 173. BD: OPERATING SEGMENTS
TABLE 174. BD: PRODUCT PORTFOLIO
TABLE 175. BUHLER: COMPANY SNAPSHOT
TABLE 176. BUHLER OPERATING SEGMENTS
TABLE 177. BUHLER: PRODUCT PORTFOLIO
TABLE 178. ENABLE: COMPANY SNAPSHOT
TABLE 179. ENABLE: OPERATING SEGMENTS
TABLE 180. ENABLE: PRODUCT PORTFOLIO
TABLE 181. ENABLE.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 182. EOFLOW: COMPANY SNAPSHOT
TABLE 183. EOFLOW: OPERATING SEGMENTS
TABLE 184. EOFLOW: PRODUCT PORTFOLIO
TABLE 185. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 186. GERRESHEIMER: OPERATING SEGMENTS
TABLE 187. GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 188. GERRESHEIMER.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 189. INSULET: COMPANY SNAPSHOT
TABLE 190. INSULET SEGMENTS
TABLE 191. INSULET: PRODUCT PORTFOLIO
TABLE 192. INSULET.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 193. MEDTRONIC: COMPANY SNAPSHOT
TABLE 194. MEDTRONIC: OPERATING SEGMENT
TABLE 195. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 196. UNITED THERAPEUTICS: COMPANY SNAPSHOT
TABLE 197. UNITED THERAPEUTICS: OPERATING SEGMENTS
TABLE 198. UNITED THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 199. XX.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 200. WEST: COMPANY SNAPSHOT
TABLE 201. WEST: OPERATING SEGMENTS
TABLE 202. WEST: PRODUCT PORTFOLIO
TABLE 203. YPSOMED: COMPANY SNAPSHOT
TABLE 204. YPSOMED: OPERATING SEGMENTS
TABLE 205. YPSOMED: PRODUCT PORTFOLIO
TABLE 206. YPSOMED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
List of Figures
FIGURE 01. WEARABLE INJECTOR MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. PATENTS ANALYSIS BY YEAR, 2018 THROUGH 2021
FIGURE 14. YEAR 2020 PATENT ANALYSIS, BY COUNTRY
FIGURE 15. WEARABLE INJECTORS CLINICAL TRIALS, BY REGION, 2018-2021
FIGURE 16. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR ON BODY, BY COUNTRY, 2020-2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR OFF-BODY, BY COUNTRY, 2020-2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR DISPOSABLE INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR SEMI-REUSABLE INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR ELECTRONIC INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR MECHANICAL INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR OTHER INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR SPRING-BASED INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 25. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 26. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR MOTOR DRIVEN INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 27. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR COLLAPSIBLE RESERVOIR, BY COUNTRY, 2020-2030 (%)
FIGURE 28. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR PRESSURIZED GAS INJECTORS, BY COUNTRY, 2020-2030 (%)
FIGURE 29. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR DIABETES, BY COUNTRY, 2020-2030 (%)
FIGURE 30. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2030 (%)
FIGURE 31. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2020-2030 (%)
FIGURE 32. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR OTHER, BY COUNTRY, 2020-2030 (%)
FIGURE 33. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR CLINICS, BY COUNTRY, 2020-2030 (%)
FIGURE 34. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
FIGURE 35. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020-2030 (%)
FIGURE 36. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2030 (%)
FIGURE 37. COMPARATIVE ANALYSIS OF WEARABLE INJECTOR MARKET FOR OTHER, BY COUNTRY, 2020-2030 (%)
FIGURE 38. BD: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. BD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 41. BUHLER: NET SALES, 2018-2020 ($MILLION)
FIGURE 42. BUHLER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43. BUHLER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 44. GERRESHEIMER: NET SALES, 2018-2020 ($MILLION)
FIGURE 45. GERRESHEIMER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46. GERRESHEIMER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47. INSULET: NET SALES, 2018-2020 ($MILLION)
FIGURE 48. INSULET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49. INSULET: REVENUE SHARE BY REGION, 2020(%)
FIGURE 50. MEDTRONIC: NET SALES, 2020 ($MILLION)
FIGURE 51. MEDTRONIC: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 52. MEDTRONIC: REVENUE SHARE BY REGION 2020(%)
FIGURE 53. UNITED THERAPEUTICS: NET SALES, 2018-2020 ($MILLION)
FIGURE 54. UNITED THERAPEUTICS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 55. UNITED THERAPEUTICS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 56. WEST: NET SALES, 2018-2020 ($MILLION)
FIGURE 57. WEST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 58. WEST: REVENUE SHARE BY REGION, 2020(%)
FIGURE 59. YPSOMED: NET SALES, 2018-2020 ($MILLION)
FIGURE 60. YPSOMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 61. YPSOMED: REVENUE SHARE BY REGION, 2020(%)

Companies Mentioned

  • Enable Injections
  • United Therapeutics (Steadymed Therapeutics, Inc.)
  • Insulet Corporation
  • Medtronic Plc
  • Sensile Medical Ag
  • West Pharmaceutical Services Inc.
  • Becton Dickinson And Company
  • Buhler Motor Gmbhy
  • Psomed
  • Eoflow

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...